Disability Outcomes in the N-MOmentum Trial of Inebilizumab in Neuromyelitis Optica Spectrum DisorderRomain Marignier, Bruce Cree, Ari Green et al.|Neurology Neuroimmunology & Neuroinflammation|2021Cited by 42